| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.6 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |